Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent years.
about
Treatment of relapsed and refractory multiple myelomaAutotransplant with and without induction chemotherapy in older multiple myeloma patients: long-term outcome of a randomized trial.Upfront autologous stem cell transplantation for newly diagnosed elderly multiple myeloma patients: a prospective multicenter study.Geriatric assessment in multiple myeloma patients: validation of the International Myeloma Working Group (IMWG) score and comparison with other common comorbidity scores.Autologous haematopoietic cell transplantation in elderly patients with multiple myeloma.Managing multiple myeloma in elderly patients.Oral ixazomib maintenance therapy in multiple myeloma.Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting).Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma.Efficacy and safety of high-dose chemotherapy with autologous stem cell transplantation in senior versus younger adults with newly diagnosed multiple myeloma.VTD-melphalan is well tolerated and results in very high rates of stringent CR and MRD-negative status in multiple myeloma.Autologous stem cell transplant for multiple myeloma patients 70 years or older.Efficacy and safety of autologous hematopoietic cell transplantation in elderly patients with multiple myeloma: a retrospective national multi-site cohort study.Observational study of multiple myeloma in Latin America.Autotransplants in older multiple myeloma patients: hype or hope in the era of novel agents?From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives.Melphalan 140mg/m2 or 200mg/m2 for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party.Circulating CD3+CD4+CD161+ Cells Are Associated with Early Complications after Autologous Stem Cell Transplantation in Multiple Myeloma.
P2860
Q26749180-B3C1EB75-BEF8-4503-B788-93E42FCAAA23Q38385465-F11FA4EE-9F02-460A-A8B8-F7621C57C827Q38385471-99308068-6E41-4F38-967A-62409B186758Q38389362-87623652-0DC8-46BD-875D-6C77787CB429Q38554884-2674E0F7-42CC-48A0-8C18-73272A9D65F9Q38605484-9501902E-9712-4E21-A388-8AC5360622D9Q38640514-5DD3F300-BA75-4973-B746-039E1B9913EBQ38688055-727AE030-45C4-44D1-8921-7200BD82BB4FQ38797546-0EAB4833-934D-425C-9D87-4172565847EFQ39010793-7CDB2F89-2A4B-4DC4-A8A4-105408B07043Q39103567-5A911CE9-129D-47DA-87A1-251940552A3AQ39633772-C47D3C98-581E-4251-8CEB-8F39597EBC95Q40389797-CC81E9D6-3F41-4E9B-8CE4-C648B1D97421Q40488479-A2FC488A-C12C-4AAB-BA97-04155DA8BB2DQ42362041-C86FA279-93CA-45EE-9BA6-D1BA7373E8C5Q47794767-B9EAB44C-9AE1-4F36-B959-06F6DFCBE74BQ50020987-B689D748-9FCD-461A-BDB6-AF2267C89410Q55117360-8F854950-A296-4805-9F27-394720FB629F
P2860
Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent years.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Trends in autologous hematopoi ...... erly patients in recent years.
@ast
Trends in autologous hematopoi ...... erly patients in recent years.
@en
Trends in autologous hematopoi ...... erly patients in recent years.
@en-gb
type
label
Trends in autologous hematopoi ...... erly patients in recent years.
@ast
Trends in autologous hematopoi ...... erly patients in recent years.
@en
Trends in autologous hematopoi ...... erly patients in recent years.
@en-gb
prefLabel
Trends in autologous hematopoi ...... erly patients in recent years.
@ast
Trends in autologous hematopoi ...... erly patients in recent years.
@en
Trends in autologous hematopoi ...... erly patients in recent years.
@en-gb
P2093
P2860
P50
P356
P1476
Trends in autologous hematopoi ...... erly patients in recent years.
@en
P2093
A M Stoppa
H Goldschmidt
L Garderet
P Sonneveld
P2860
P2888
P304
P356
10.1038/BMT.2014.255
P407
P577
2014-11-10T00:00:00Z
P5875
P6179
1042537292